Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Yoshito, Matsuyama"'
Autor:
Reiko Mitsueda, Anri Gen, Yoshitaka Fujiki, Naomi Gondo, Mutsumi Sato, Junko Kawano, Koichi Kuninaka, Shuichi Kanemitsu, Megumi Teraoka, Yoshito Matsuyama, Shinichi Baba, Sugako Nomoto, Robert Sloan, Yoshiaki Rai, Yoshiaki Sagara, Yasuaki Sagara
Publikováno v:
Cancer Research. 82:P3-18
Background The suture scaffold technique (SST) is one of the oncoplastic techniques used for breast-conserving surgery (BCS), first reported in 2010. There is no report about the cosmetic outcome of SST, so we investigated SST patient satisfaction co
Autor:
Reiko Mitsueda, Anri Gen, Yoshitaka Fujiki, Naomi Gondo, Mutsumi Sato, Junko Kawano, Koichi Kuninaka, Shuichi Kanemitsu, Megumi Teraoka, Yoshito Matsuyama, Shinichi Baba, Sugako Nomoto, Robert Sloan, Yoshiaki Rai, Yoshiaki Sagara, Yasuaki Sagara
Publikováno v:
Annals of surgical oncology. 29(6)
Optimal cosmetic results after breast-conserving surgery (BCS) improve patient satisfaction. The suture scaffold technique (SST) is a breast reconstruction technique that all breast surgeons can perform without any extensive training in plastic surge
Autor:
Reiko Mitsueda, Anri Gen, Yoshitaka Fujiki, Naomi Gondo, Mutsumi Sato, Junko Kawano, Koichi Kuninaka, Shuichi Kanemitsu, Megumi Teraoka, Yoshito Matsuyama, Shinichi Baba, Sugako Nomoto, Robert Sloan, Yoshiaki Rai, Yoshiaki Sagara, Yasuaki Sagara
Publikováno v:
Annals of Surgical Oncology. 29:3838-3838
Autor:
Ayami Matsukata, Shugo Tamada, Yoshiaki Sagara, Shinichi Baba, Yoshiaki Rai, Yoshito Matsuyama, Yasuaki Sagara, Yoshiatsu Sagara, Yasuyo Ohi, Mitsutake Ando, Daisuke Yotsumoto
Publikováno v:
Breast Cancer. 20:181-186
The one-step nucleic acid amplification (OSNA) method can assess the expression level of cytokeratin 19 mRNA in sentinel lymph nodes in breast cancer. We compared the time required for diagnosis and concordance of results between the OSNA method and
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 72:10-14
左乳房に腫瘤を形成,画像診断で乳癌を否定できず組織生検を施行,巨細胞性動脈炎Giant cell arteritis(GCA)の診断に至った症例を経験した.症例は74歳,女性.左乳房に圧痛を伴う腫瘤を
Autor:
Yoshiaki Rai, Yasuaki Sagara, Yasuyo Ooi, Taeko Kukita, Toshiki Taguchi, Yoshiaki Sagara, Syugo Tamada, Shinichi Baba, Yoshito Matsuyama, Mitsutake Ando, Yoshiatsu Sagara
Publikováno v:
Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 17:31-36
Autor:
Yasuyuki Sagara, Tetsuaki Rai, Taeko Kukita, Yoshiaki Sagara, Shinsaku Tsuchimochi, Tetsuya Takahama, Yoshito Matsuyama, Fumiyo Yonenaga, Yasuyo Oi, Mitsutake Ando, Yoshiatsu Sagara
Publikováno v:
Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 15:221-226
Autor:
Yoshiaki, Rai, Yoshiatsu, Sagara, Yasuyo, Ooi, Yasuaki, Sagara, Yoshiaki, Sagara, Shinichi, Baba, Syugo, Tamada, Yoshito, Matsuyama, Mitsutake, Ando
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 36(3)
A 63-year-old woman had a 12 cm tumor on her right breast with broad skin redness, satellite lesions and 8 cm ipsilateral lymph nodes swelling(T4bN2aM0, Stage IIIB). Core needle biopsy and immunohistochemistry of breast tumor showed invasive ductal c
Autor:
Yoshiaki, Sagara, Yoshiaki, Rai, Yoshiatsu, Sagara, Yoshito, Matsuyama, Shinichi, Baba, Shugo, Tamada, Yasuaki, Sagara, Mitsutake, Ando
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 36(2)
A paclitaxel injection NK (NK) is a generic product containing the same amount of ingredient as a Taxol Injection. We examined the pharmacokinetics and safety of NK compared to the original product in breast cancer patients. As a result, the transiti
Autor:
Yasuaki Sagara, Yoshito Matsuyama, Yoshiaki Sagara, Shinichi Baba, Shugo Tamada, Tsutomu Douchi, Yoshiatsu Sagara, Fumiko Dokiya, Mitsutake Ando, Yoshiaki Rai, Yasuyo Ohi, Shoichiro Kosha
Publikováno v:
Breast cancer (Tokyo, Japan). 17(3)
Although anastrozole (ANA), an aromatase inhibitor (AI), has been widely used for breast cancer patients; adverse events during ANA therapy in Japanese patients have not been reported. The study included 656 postmenopausal breast cancer patients rece